Home News & Updates Pharma Industry Developments in Corporate Governance

Pharma Industry Developments in Corporate Governance

by Nigel Kendall

The global pharma industry is evolving. Following high profile failures of mergers the pharma sector is choosing strategic alliances and focussing on specific fields to counter challenges of rising costs of new drug development and patent expiry.


Our definition of good corporate governance is holistic, as regular readers will know. Hence we aren’t primarily concerned by the shenanigans of boardroom goings on, or compliance with relevant regulations, important though this may be. To us, the critical judgement is whether the organisation is fulfilling the aims of its key stakeholders and doing so in an ethical and effective manner with due transparency and accountability.

So we thought we would take a brief look this year at corporate governance in the pharmaceutical…

Please register to access this content.

Related Articles

Leave a Comment